BFSG LLC
BMRN icon

BFSG LLC’s BioMarin Pharmaceuticals BMRN Stock Holding History

BFSG LLC’s Portfolio BMRN Stock Details BMRN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$1.05M Buy
+17,538
New +$1.1M 0.09% 175
2020
Q3 		– Sell
-6,606
Closed -$815K – 185
2020
Q2 		$815K Sell
6,606
-558
-8% -$55.5K 0.18% 97
2020
Q1 		$605K Sell
7,164
-91
-1% -$7.84K 0.16% 107
2019
Q4 		$613K Buy
+7,255
New +$548K 0.12% 141

Other funds holding BMRN

Swedbank
Swedbank Stockholm, Sweden $118B AUM 40.52% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
ARGA Investment Management
ARGA Investment Management Stamford, Connecticut $3.94B AUM 28.9% 1-Year Est. Return
Fort Washington Investment Advisors
Fort Washington Investment Advisors Cincinnati, Ohio $19.7B AUM 20.11% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $87.8B AUM 20.94% 1-Year Est. Return
Covea Finance
Covea Finance Paris, France $3.07B AUM 27.46% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return
KBC Group
KBC Group Brussels, Belgium $47.9B AUM 37.61% 1-Year Est. Return
Mutual of America Capital Management
Mutual of America Capital Management New York $10.1B AUM 33.74% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $52.9B AUM 36.03% 1-Year Est. Return

BFSG LLC's BMRN Position: Q3 2026 in Review

BFSG LLC opened a new position in BioMarin Pharmaceuticals (BMRN) in Q3 2026: 17,538 shares worth $1.05M. The stake represents 0.09% of the portfolio and ranks #175 among its holdings. This is a return to the name: BFSG LLC previously reported a position in BMRN as recently as Q2 2020.

BFSG LLC first reported a position in BMRN in Q4 2019 and has held it in 4 quarters since. 156 funds tracked by Wall St. Rank hold BMRN as of Q3 2026.

  • BFSG LLC held 17,538 shares of BioMarin Pharmaceuticals worth $1.05M as of Q3 2026.
  • BioMarin Pharmaceuticals was a new BFSG LLC position in Q3 2026.
  • BioMarin Pharmaceuticals made up 0.09% of BFSG LLC's portfolio in Q3 2026, its #175 holding.
  • BFSG LLC first reported a position in BioMarin Pharmaceuticals in Q4 2019 and has held it in 4 quarters since.
  • 156 funds tracked by Wall St. Rank held BioMarin Pharmaceuticals as of Q3 2026.

Based on BFSG LLC's 13F filing for Q3 2026, filed 30 Oct 2026.